{"id":1238158,"date":"2025-03-09T13:34:00","date_gmt":"2025-03-09T17:34:00","guid":{"rendered":"https:\/\/www.prime-wow.com\/?p=1238158"},"modified":"2025-03-09T13:34:00","modified_gmt":"2025-03-09T17:34:00","slug":"stem-cell-therapy-trial-reverses-irreversible-damage-to-cornea","status":"publish","type":"post","link":"https:\/\/www.prime-wow.com\/?p=1238158","title":{"rendered":"Stem Cell Therapy Trial Reverses ‘Irreversible’ Damage to Cornea"},"content":{"rendered":"
Damaged corneas were repaired at a Harvard teaching hospital in a unique clinical trial, reports New Atlas:<\/p>\n

Since it’s on the frontline of potential hazards from the outside world, the cornea features a population of limbal epithelial stem cells, which repair minor damage to keep the surface smooth and functional… The new study, conducted by scientists at Massachusetts Eye and Ear, investigated a new treatment called cultivated autologous limbal epithelial cells (CALEC). This involves removing stem cells from a patient’s uninjured eye, growing their population in the lab for a few weeks, then surgically transplanting them into the injured eye.
\nThe phase 1\/2 trial recruited 14 patients to undergo the procedure, and followed them for 18 months afterwards… By the first checkup at three months, the corneas of seven (50%) of the participants had been completely restored. By the 12-month mark, that number had increased to 11 (79%) patients. Two other participants met the definition for partial success, so the team claims an overall success rate of 92% for CALEC.<\/p>\n

\n<\/a>
\n<\/a><\/p>\n<\/div>\n

Read more of this story<\/a> at Slashdot.<\/p>\n